CVRx Inc
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 200
- Market Cap
- -
- Introduction
CVRx, Inc. engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It operates through the United States, Germany, and Other Countries geographical segments. The company was founded by Robert S. Kieval and Tyler P. Lipschultz in August 2001 and is headquartered in Minneapolis, MN.
BAROSTIM NEO System in the Treatment of Heart Failure
- Conditions
- Heart Failure
- Interventions
- Device: BAROSTIM NEO SystemDrug: Medical Management
- First Posted Date
- 2011-11-16
- Last Posted Date
- 2019-11-04
- Lead Sponsor
- CVRx, Inc.
- Target Recruit Count
- 94
- Registration Number
- NCT01471860
- Locations
- 🇨🇦
St. Boniface Hospital, Winnipeg, Manitoba, Canada
🇩🇪Vivantes Hospital Berlin, Berlin, Germany
🇩🇪Immanuel Hospital Bernau-Heart Center Brandenburg, Bernau, Germany
Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension
- Conditions
- High Blood Pressure
- Interventions
- Device: BAROSTIM NEO SystemDrug: Medical Management
- First Posted Date
- 2011-11-16
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- CVRx, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT01471834
- Locations
- 🇨🇦
University of Alberta - Edmonton, Edmonton, Alberta, Canada
🇩🇪University Hospital Cologne, Cologn, Germany
🇩🇪Klinkum St. George Leipzig, Leipzig, Germany
Rheos Feasibility Trial
- Conditions
- Hypertension
- Interventions
- Other: Standard of care medical managementDevice: Implantation of the Rheos System
- First Posted Date
- 2010-02-26
- Last Posted Date
- 2019-07-02
- Lead Sponsor
- CVRx, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT01077180
Rheos System for the Treatment of HFpEF Heart Failure
- Conditions
- Heart Failure
- Interventions
- Device: Rheos® system
- First Posted Date
- 2009-08-12
- Last Posted Date
- 2021-04-08
- Lead Sponsor
- CVRx, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT00957073
- Locations
- 🇺🇸
Cardiology Associates of Mobile, Inc., Mobile, Alabama, United States
🇺🇸University of Southern California, Los Angeles, California, United States
🇺🇸Ohio State University, Columbus, Ohio, United States
Rheos® Diastolic Heart Failure Trial
- Conditions
- Diastolic Heart Failure
- Interventions
- Device: Rheos Baroreflex Activation Therapy System
- First Posted Date
- 2008-07-21
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- CVRx, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT00718939
- Locations
- 🇩🇪
Krankenhaus Reinbek St.Adolfsstif, Hamburg-Reinbek, Germany
🇩🇪Medizinische Hoschschule Hannover, Hannover, Germany
🇩🇪University of Cologne, Koeln, Germany
Device Based Therapy in Hypertension Trial
- Conditions
- Hypertension
- Interventions
- Device: Rheos Baroreflex Hypertension Therapy System
- First Posted Date
- 2008-07-04
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- CVRx, Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT00710190
- Locations
- 🇩🇪
University Hospital Bad Oeynhausen, Bad Oeynhausen, Germany
🇩🇪University Hospital Hannover, Hannover, Germany
🇩🇪Uniklinik Essen, Essen, Germany
Device Based Therapy in Hypertension Extension Trial
- Conditions
- Hypertension
- First Posted Date
- 2008-07-04
- Last Posted Date
- 2011-10-31
- Lead Sponsor
- CVRx, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT00710294
- Locations
- 🇳🇱
Academisch Ziekenhuis Maastricht, Maastricht, Netherlands
🇨🇭Inselspital Bern, Bern, Switzerland
🇩🇪Charité Campus Buch, Berlin, Germany
Rheos® Pivotal Trial
- Conditions
- Hypertension
- Interventions
- Device: Rheos® Baroreflex Hypertension System
- First Posted Date
- 2007-03-01
- Last Posted Date
- 2017-03-20
- Lead Sponsor
- CVRx, Inc.
- Target Recruit Count
- 591
- Registration Number
- NCT00442286
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸University of Chicago, Dept. of Medicine, Section of Endocinology, Diabetes & Metabolism, Chicago, Illinois, United States
🇺🇸The Lindner Clinical Trial Center, Cincinnati, Ohio, United States